Chemist Warehouse a boon for EBOS

EBOS has announced “strong growth” in revenue and earnings with a pharmacy business boosted by its agreement with Chemist Warehouse The group has reported a significant increase in first half earnings, with revenue of $4.4 billion – up 25.2% - and statutory EBITDA of $167.2 million, up 36.4%. Statutory net profit after tax was $87.1